Disposable Syringe Markets

  • June 2013
  • -
  • TriMark Publications
  • -
  • 295 pages

This TriMark Publications report examines the disposable syringe markets as well as the supplies utilized in clinics and by patients directly in their homes to diagnose and monitor disease and to administer medications. This analysis is intended to provide basic market data pertaining to the U.S. and worldwide market segments. Each market segment is analyzed to determine size, growth rates, sales projections and factors influencing growth in the U.S. and internationally. Unit and dollar volume are used to indicate market sizes. Additionally, this review examines industry challenges and potential threats to syringe and needle supplies manufacturers and makes strategic recommendations for boosting market share. The emphasis is on those companies actively developing and marketing products to hospitals, physicians and the general public for medically related uses. The disposable syringe market segments are identified as: 1) total reusable needle and syringe market; 2) total disposable needle and syringe market; 3) prefilled syringes; 4) safety syringes; 5) insulin injector pens; 6) needleless injectors; 7) vaccination injectors; 8) blood collection needles and syringes; 9) hypodermic needles and syringes market; 10) insulin needles and syringes market; 11) specialty needles and syringes market; and 12) needleless injector market.

Table Of Contents

TABLE OF CONTENTS

1. Introduction 14
1.1 Statement of Report 14
1.2 About this Report 14
1.2.1 Scope of the Report 14
1.2.2 Objectives 15
1.2.3 Methodology 16
1.3 Executive Summary 17

2. Syringe Types: An Overview 19
2.1 Disposable Syringes 19
2.2 Safety Syringes 19
2.2.1 Available Safety Syringe Technologies 19
2.2.2 Retrofitted Syringes 20
2.2.3 Automatically Retractable Syringes 20
2.2.4 Manually Retractable Syringes 20
2.2.5 Insulin Syringes 21
2.2.6 Tuberculin Syringes 21
2.2.7 Prefilled Syringes 22
2.2.7.1 Components of a Prefilled Syringe 22
2.2.7.2 Benefits of Prefills 23
2.2.7.3 Prefills: The Future of Drug Delivery 23
2.2.7.4 Wider Applications of Prefilled Syringes 24
2.2.7.5 Making Improvements in Components of Prefilled Syringes 24
2.2.7.6 Biologic Drugs and Overfill 24
2.2.7.7 Benefits of Cyclic Olefin Polymers 24
2.2.7.8 Overcoming Variability in Glass Syringes 25
2.2.7.9 Impact of Silicone Oil on Delivery 25
2.2.7.10 Migrating Risk for Protein Aggregation 25
2.2.7.11 Key Advantages of Prefilled Syringes 25
2.2.8 Production of Standard Prefilled Syringes 26
2.2.8.1 Attachment of Safety Features in Prefilled Syringes 27
2.2.9 Available Prefilled Syringes in the Market 27
2.2.9.1 Baxter BioPharma Solutions 28
2.2.9.2 BD Medical’s Prefilled Segment 29
2.2.9.3 Catalent Pharma Solutions 30
2.2.9.4 Cook Pharma’s Filling and Packaging 30
2.2.9.5 Gerresheimer AG’s Syringe Designs 31
2.2.9.6 Unilife Corporation’s New Approach 31
2.2.9.7 West Pharmaceutical Services, Inc.’s Prefilled Syringes 32
2.3 Pen Injectors 32
2.3.1 Insulin Pens 33
2.3.2 Buyer’s Guide for Reusable Insulin Pens 33
2.3.2.1 Technical Considerations for Insulin Pens 34
2.3.2.2 Technical Considerations for Insulin Cartridges 34
2.3.2.3 Technical Considerations for Pen Needles 34
2.3.2.4 Device Considerations 34
2.3.2.5 User Considerations 35
2.3.3 Market Review of Selected Insulin Pens 36
2.3.3.1 Autopen 24 and Autopen Classic from Owen Mumford 36
2.3.3.2 HumaPen Luxura and Luxura HD from Eli Lilly 36
2.3.3.3 HumaPen Memoir from Eli Lilly 37
2.3.3.4 NovoPen 3 and NovoPen Junior/Demi from Novo Nordisk 37
2.3.3.5 OptiClik from Sanofi-Aventis 37
2.3.3.6 OptiPen Pro from Sanofi-Aventis 38
2.4 Advanced Injection Devices 38
2.4.1 Insulin Delivery Device Technology 38
2.4.2 Biologic Delivery Device Technology 39
2.4.3 Alternative Delivery Technologies 40
2.5 Needle-Free Injectors 40
2.5.1 Needleless Injector from Injex 41
2.5.2 Jet Syringes from Injex 41
2.5.3 Syrijet 42
2.5.4 PenJet 42
2.5.5 Needle-Free Injector for Human Growth Hormones 42

3. Award Winning Syringes 44
3.1 Episure AutoDetect Syringe 44
3.2 ConfiDose 44
3.3 Humatrope Reconstitution Devices 45
3.4 Vascez Plungerless Syringe 45
3.5 Powr Syringe Injector 45
3.6 NovoFine Autocover Automatic Safety Pen Needle 46
3.7 Rev Vac Auto-Retractable Vacuum Safety Syringe 46

4. Syringe Industry: Overview 47
4.1 Common Diseases Transmitted by Unsafe Needle Use and Needlesticks 47
4.2 Most Common Instances of Needlestick Injuries 48
4.3 Needle Phobia and Patients’ Anxieties 48
4.4 Global Transition to Safety Medical Devices 48
4.5 U.S. Regulation 49
4.6 Worldwide Regulation 50
4.7 Enforcing Compliance with Sharps Safety Legislation 50
4.8 Example of an OSHA Violation 50
4.9 Target Market Awaiting Premium Products 50
4.10 Current Types of Safety Syringes 51
4.10.1 Safety Syringes with a Needlestick Protection Device 52
4.10.2 Needle Guard 52
4.10.3 Needle Sheath 53
4.10.4 Retractable Syringes 53
4.10.4.1 Spring-Based, Non-Controlled, Retracting Needle Syringe 53
4.11 Need for Safety Syringe Products 54
4.12 Limitations of Existing Clinical Syringes 55
4.13 Limitations of Existing Prefilled Syringes 55
4.14 Market Expansion for Safety Syringes 55
4.15 Technological Advancements in Disposable Syringes 55
4.16 Reconstitution inside Sterile Syringes 56
4.16.1 Vetter Lyo-Ject 56
4.17 Plungerless Prefilled Syringes 56
4.18 The Disposable UniJect 56
4.19 Needle-Free Injection 57

5. Disposable Syringes: Market Analysis 58
5.1 Volume of Syringes Used in Healthcare 58
5.2 Syringe Sizes Required for Injectable Drugs 59
5.3 Domination of Syringes in Parenteral Drug Delivery Market 59
5.4 Global Market for Disposable Syringes 60
5.4.1 Global Market for Disposable Syringes by Product Segmentation 61
5.4.2 Global Market for Safety Syringes by Segmentation 61
5.4.3 Combined Market for Injection Devices 62
5.5 U.S. Market for Hypodermic Safety Syringes 63
5.5.1 Disposable Syringes: U.S. Market Segments 63
5.5.2 Types of Safety Syringes Used in U.S. Hospitals 64
5.5.3 U.S. Adoption of Safety Syringes 65
5.5.4 Competitive Landscape in the U.S. 66
5.5.5 Price of Safety Syringes in the U.S. 66
5.5.6 U.S. Disposable Syringe Market 67
5.5.7 U.S. Safety Hypodermic Syringe Market 67
5.6 European Market for Disposable Syringes 68
5.6.1 European Market for Safety Syringes 69
5.7 Prefill Market Trends 69
5.7.1 The Shift from Vials to Prefilled Syringes 70
5.7.2 Prefilled Syringes: Market Dynamics 70
5.7.3 Importance of Prefilled Syringes to Extend Brand Life 71
5.7.4 Biggest Markets for Prefilled Syringes 71
5.7.5 Dealing with the Latest Trends in Prefilled Syringe Market 72
5.7.6 Market Opportunities for Prefilled Syringes 72
5.7.7 Pharmaceutical Share of Key Prefilled Therapeutic Market 73
5.7.8 Specialty Pipeline Drugs Targeted for Use with Prefilled Syringes 74
5.7.9 Therapeutic Usage of Prefilled Syringes 75
5.7.9.1 Anti-Infectives in Prefilled Syringes 75
5.7.9.2 Cardiovascular Drugs in Prefilled Syringes 76
5.7.9.3 Central Nervous System Drugs in Prefilled Syringes 76
5.7.9.4 Hematology Drugs in Prefilled Syringes 76
5.7.9.5 Human Growth Hormones in Prefilled Syringes 76
5.7.9.6 Musculoskeletal Drugs in Prefilled Syringes 77
5.7.9.7 Obstetrics Drugs in Prefilled Syringes 77
5.7.9.8 Oncology Drugs in Prefilled Syringes 77
5.7.9.9 Vaccines in Prefilled Syringes 77
5.7.10 Flexible Administration Requirements of Prefilled Syringes 77
5.7.11 Biotech Blockbusters Available in Prefilled Syringes 78
5.7.12 Selected Drugs Available in Prefilled Syringes 79
5.7.12.1 Ovidrel Prefilled Syringe 79
5.7.12.2 Enbrel Prefilled Syringe 79
5.7.12.3 Biocon’s Prefilled Safety Syringes 79
5.7.12.4 Pegasys 80
5.7.12.5 Afluria 80
5.7.12.6 Enzira 81
5.7.12.7 Fluzone Vaccine 81
5.7.12.8 Novolin N FlexPenÔ Prefilled Insulin Syringes 81
5.7.12.9 NovoLog® Insulin Prefilled Syringe 82
5.7.12.10 GlaxoSmithKline’s Vaccines in Prefilled Syringes 82
5.7.13 Selected Providers of Syringe Prefilling Services and Products 82
5.7.13.1 Althea Technologies, Inc. 82
5.7.13.2 Althea’s Clinical Manufacturing 83
5.7.13.3 Althea’s Fill/Finish Services 83
5.7.13.4 Althea’s Contract Manufacturing 83
5.7.14 Baxter International, Inc. 84
5.7.14.1 Baxter’s Contract Manufacturing 85
5.7.14.2 Baxter’s Fill/Finish Services 85
5.7.14.3 Baxter’s Prefilled Syringes Capability 85
5.7.14.4 Baxter’s Vials 86
5.7.14.5 Baxter’s Cartridges 86
5.7.15 Becton Dickinson and Company 87
5.7.15.1 BD’s Prefilled Syringe Services 87
5.7.15.2 BD Hypak SCF 87
5.7.15.3 BD Sterifill SCF 88
5.7.15.4 BD Physioject 88
5.7.15.5 BD Liquid Dry Disposable Pen Injector 89
5.7.15.6 BD Pens Customized Self-Injection Systems 89
5.7.15.7 BD Soluvia Prefillable Microinjection System 90
5.7.16 Catalent Pharma Solutions, Inc. 90
5.7.17 Hyaluron Contract Manufacturing 91
5.7.17.1 Hyaluron’s Syringe Filling 91
5.7.17.2 Vetter Pharma Fertigung GmbH 91
5.7.17.3 Vetter’s Development Service 92
5.7.17.4 Vetter’s Commercial Manufacturing 92
5.7.18 Global Market for Prefilled Syringes 92
5.7.18.1 Steady Growth in Consumption of Prefilled Syringe Units 93
5.7.19 U.S. Market for Prefilled Syringes 94
5.7.20 Rapid Adoption of Prefilled Syringes for Injectables 94
5.7.21 Pharmaceutical Consumption of Prefilled Syringes 95
5.7.22 Market for Pharmaceutical Prefilled Syringes 96
5.7.22.1 Global Market for Prefilled Pain Management Drugs 96
5.7.22.2 Global Sales of Enbrel in Prefilled Syringes 97
5.7.22.3 Global Market for Prefilled Psoriasis Drugs 98
5.7.22.4 Global Market for Prefilled Anemia Drugs 99
5.7.22.5 Global Market for Prefilled Disposable Insulin Delivery Devices 99
5.7.22.6 Global Market for Insulin in Various Devices 100
5.7.22.7 Global Market for Oncology Drugs in Prefilled Syringes 101
5.7.22.8 Global Market for Multiple Sclerosis Drugs in Prefilled Syringes 102
5.7.22.9 Market Leaders in Multiple Sclerosis Drugs in Prefilled Syringes 103
5.7.22.10 Global Market for Prefilled Arthritis Drugs 103
5.7.22.11 Global Market for Vaccines in Prefilled Syringes 104
5.7.22.12 Market Leaders in Injectable Vaccines 105
5.7.22.13 Market Leaders in Injectable Anticoagulants 106
5.7.23 Market Leaders in Injectable Anti-Inflammatory Drugs 107
5.7.24 Market Leaders in Injectable Hematology Drugs 108
5.7.25 Market Leaders in Injectable Obstetrics Drugs 109
5.8 Insulin Pens: Market Analysis 110
5.8.1 Disposable Insulin Pens 110
5.8.2 Refillable Pens 110
5.8.3 Pen Needles 110
5.8.4 Benefits and Patient Preferences of Insulin Pens 111
5.8.5 Disadvantages of Pen Syringes 111
5.8.6 Insulin Pens and Hospital Bills 112
5.8.7 Market for Insulin Pen 112
5.9 Global Market for Auto-Injectors/Auto-Infusers 113
5.9.1 U.S. Leaders in Insulin Pump Market 114
5.10 The Growth Market for Self-Injection 115

6. Company Profiles 116
6.1 Abbott Laboratories 116
6.1.1 Abbott’s Syringe Products 116
6.1.1.1 Precision Sure-Dose syringes 116
6.1.1.2 Humira Prefilled Syringe 117
6.1.1.3 Humira Pen 117
6.2 Albert David Limited 117
6.3 Alshifa Medical Syringes Manufacturing Company Ltd. 118
6.4 Althea Technologies, Inc. 119
6.5 Baxter International, Inc. 120
6.5.1 Baxter’s Anesthesia Business 120
6.5.2 Baxter’s Biosurgery 120
6.5.3 Baxter’s Clinical Nutrition Business 120
6.5.4 Baxter’s Hemophilia Therapies 121
6.5.5 Baxter’s Infusion Systems 121
6.5.6 Baxter’s Pharmaceuticals and IV Solutions 121
6.5.7 Baxter’s Renal Products 121
6.5.8 Baxter’s Business Performance 121
6.6 Becton, Dickinson andamp; Co. 122
6.6.1 BD’s International Operations 122
6.6.2 BD Medical Business Segment 123
6.6.3 BD Diagnostics 124
6.6.4 BD Biosciences 124
6.6.5 BD’s Geographic Performance 125
6.6.6 BD’s Role in Designing Devices for Safe and Effective Injections and
Infusions 126
6.6.6.1 BD’s Safety-Engineered Devices 126
6.6.6.2 BD Auto-Disable Syringes 128
6.6.6.3 BD’s Insulin Syringes 130
6.6.6.4 BD’s Allergy Syringes 131
6.6.6.5 BD’s Tuberculin Syringes 132
6.6.6.6 BD’s Syringes and Needles 133
6.6.6.7 BD’s Safety-Lok Safety Syringes 134
6.6.6.8 BD’s Safety Glide Syringes 135
6.6.6.9 BD’s Eclipse Needles 136
6.6.6.10 BD’s Integra Syringes 137
6.6.6.11 BD’s PosiFlush Prefilled Syringes 137
6.7 B. Braun 138
6.7.1 B. Braun’s Hospital Care Division 139
6.7.2 B. Braun’s Aesculap Division 139
6.7.3 B. Braun’s Out-Patient Market (OPM) Division 139
6.7.4 B. Braun’s Avitum Division 140
6.7.5 B. Braun’s Overall Business Performance 140
6.7.6 Hospital Care Division’s Business 140
6.7.7 Aesculap Division’s Business 140
6.7.8 OPM Division’s Business 141
6.7.9 Avitum Division’s Business 141
6.7.10 B. Braun’s Syringe Products 141
6.7.10.1 Sterican® insulin needle 141
6.7.10.2 Omnifix® 100 Duo 142
6.7.10.3 Omnifix 100 Solo 142
6.7.10.4 Injekt® 40 Duo 143
6.7.10.5 Injekt 40 Solo 143
6.7.10.6 Omnifix 40 Duo 144
6.7.10.7 Omnifix 40 Solo 144
6.7.10.8 Omnican® 100 145
6.7.10.9 Omnican® 50 145
6.7.10.10 Omnican® 20 146
6.7.10.11 Omnican 40 146
6.7.10.12 Omnican Pen 147
6.7.10.13 Omnican® fine 147
6.8 Bioject Medical Technologies, Inc. 147
6.8.1 Bioject’s Technology 147
6.8.2 Bioject’s Products 148
6.8.2.1 Biojector 2000 148
6.8.2.2 Bioject’s Drug Reconstitution System 150
6.8.2.3 Vitajet 151
6.8.2.4 ZetaJet 151
6.9 Catalent Pharma Solutions, Inc. 151
6.9.1 Catalent’s Development and Clinical Services Segment 152
6.9.2 Catalent’s Oral Technologies Segment 152
6.9.3 Catalent’s Sterile Technologies Segment 152
6.9.4 Catalent’s Packaging Services Segment 153
6.9.5 Catalent’s Syringe Solutions 153
6.10 C.R. Bard, Inc. 154
6.10.1 Bard’s Vascular Business 154
6.10.2 Bard’s Urology Business 154
6.10.3 Bard’s Oncology Business 155
6.10.4 Bard’s Surgical Specialties Business 155
6.10.5 Bard’s Syringe Products 156
6.10.5.1 Bard’s Piston Syringes 156
6.10.5.2 Bard’s Bulb Syringes 156
6.11 Coeur, Inc. 157
6.11.1 Angiographic Syringes from Coeur 157
6.11.2 CT Syringes from Coeur 158
6.12 Covidien Ltd. 158
6.12.1 Covidien’s Medical Device Segment 159
6.12.2 Covidien’s Pharmaceutical Segment 159
6.12.3 Covidien’s Medical Supplies Segment 159
6.12.4 Covidien’s Syringes and Needles 160
6.12.4.1 Magellan Safety Needles 160
6.12.4.2 Magellan Safety Needle and Syringe Combination 160
6.12.4.3 Magellan Insulin Safety Syringe 161
6.12.4.4 Magellan Tuberculin Safety Syringe 161
6.12.4.5 Magellan Safety Blood Collection Device 161
6.12.4.6 Monoject Insulin Safety Syringe 162
6.12.4.7 Monoject Tuberculin Safety Syringe 162
6.12.4.8 Monoject 3 ml Safety Syringe 162
6.12.4.9 Monoject 6 ml Safety Syringe 163
6.12.4.10 Monoject 12 ml Safety Syringe 163
6.12.4.11 SoftPack Hypodermic Needles 163
6.12.4.12 Rigid Pack Hypodermic Needles 164
6.12.4.13 Rigid Blunt Cannulas 164
6.12.4.14 Soft Pack Tuberculin Syringes 164
6.12.4.15 Rigid Pack Tuberculin Syringes 164
6.12.4.16 SoftPack Insulin Syringes 165
6.12.4.17 Rigid Pack Insulin Syringes 165
6.12.4.18 Allergy Trays with Permanently Attached Needles 165
6.13 Henke-Sass, Wolf GmbH 165
6.13.1 Selected Products from Henke-Sass 165
6.13.1.1 Two-Part Disposable Syringes 1-50 ml 166
6.13.1.2 Three-Part Disposable Syringes 1-30 ml 166
6.13.1.3 Disposable Needles HSW FINE-JECT 167
6.14 Hindustan Syringes andamp; Medical Devices, Ltd. 167
6.14.1 Insulin Syringes from HMD 167
6.14.2 HMD’s Single-Use Needles 168
6.14.3 HMD’s Single Use Syringes 169
6.15 Hi-Tech Medical Products Ltd. 169
6.16 Hyaluron Contract Manufacturing (HCM) 170
6.16.1 HCM’s Major Markets 170
6.16.2 HCM’s Facility 170
6.16.2.1 Inova SV-122 Syringe Filler 170
6.16.2.2 Inova H3-5V Syringe Filler 170
6.16.2.3 Inova VFVM-3031 Vial Filler 170
6.17 International Medication System Ltd. 171
6.17.1 Delivery Systems from IMS 171
6.17.2 PCA Products from IMS 173
6.17.3 Phytonadione Injection USP 173
6.17.4 Lidocaine HCL Jelly, USP 2% 174
6.18 Life-Shield Products, Inc. 174
6.19 MedPro Safety Products, Inc. 176
6.19.1 MedPro’s Targeted Markets 176
6.19.2 MedPro’s Products 176
6.19.2.1 Blood Collection Safety Needle 176
6.19.2.2 Winged Safety Blood Collection Set 177
6.19.2.3 Safety Syringe with Anti-Blunting Feature 177
6.19.2.4 Prefilled Safety Syringes 177
6.19.2.5 Key-Lok Needleless IV Systems 177
6.20 Merit Medical Systems, Inc. 178
6.20.1 Merit’s Inflation Devices 178
6.20.2 Merit’s Hemostasis Valves 178
6.20.3 Merit’s Vascular Access Products 178
6.20.4 Merit’s Diagnostic Catheters, Guide Wires and Torque Devices 179
6.20.5 Merit’s Angiography and Accessories 179
6.20.6 Merit’s Safety and Waste Management Systems 179
6.20.7 Merits Obesity Products 179
6.20.8 Merit’s Drainage Catheters and Accessories 179
6.20.9 Merit’s Parentesis and Pericardiocentesis Catheters 180
6.20.10 Merit’s Therapeutic Infusion Catheters 180
6.20.11 Merit’s Dialysis and Interventional Nephrology Products 180
6.20.12 Coronary Control Syringes 180
6.20.13 Medallion Syringes 181
6.20.14 RXP Syringe 181
6.20.15 VacLok Syringes 181
6.20.16 Merit’s Manufacturing Facilities 181
6.21 Milestone Scientific 182
6.21.1 Milestone Scientific’s Product Platform 182
6.21.1.1 STA Single Tooth Anesthesia System (STA System) 182
6.21.1.2 CompuDent 183
6.21.1.3 CompuMed 183
6.21.1.4 The Wand 183
6.21.1.5 The SafetyWand 184
6.22 Novo Nordisk A/S 184
6.22.1 Novo Nordisk’s Global Diabetes Care Business 184
6.21.1.1 Novo Nordisk’s Diabetes Care Business in North America 184
6.21.1.2 Novo Nordisk’s Diabetes Care Business in Europe 184
6.21.1.3 Novo Nordisk’s International Business in Diabetes Care 185
6.21.1.4 Novo Nordisk’s Diabetes Care Business in Japan and Korea 185
6.21.1.5 Insulin Pens and Needles from Novo Nordisk 185
6.21.2 Pipeline Progress in Novo Nordisk 185
6.21.3 Novo Nordisk’s Modern Insulin Portfolio 186
6.22 Owen Mumford Ltd. 188
6.22.1 Autopen® 188
6.22.2 Autoject 2 189
6.22.3 Unifine Pentips 190
6.22.4 UniGuard 190
6.23 Plas-Pak Industries, Inc. 190
6.23.1 Disposable Veterinary Syringes 191
6.23.2 Dual Syringe and Dental Syringe from Plas-Pak 191
6.23.3 Manual Dual Syringes 192
6.24 Retractable Technologies, Inc. 193
6.24.1 Retractable Technologies’ VanishPoint Products 193
6.25 Revolutions Medical Corporation 195
6.25.1 RevVac Safety Syringe 196
6.26 Safety Syringes, Inc. 196
6.26.1 UltraSafe Needle Guards 197
6.26.2 UltraSafe Passive Needle Guard 197
6.26.3 UltraSafe Passive Needle Guards for Luer Lock and Luer Slip Syringe 198
6.26.4 UltraSafe Automated Assembly 198
6.26.5 UltraSafe Product Development 198
6.27 Smiths Medical International/Medex, Inc. 199
6.27.1 Smiths Medical’s Markets 199
6.27.1.1 Smiths’ Medication Delivery Segment 200
6.27.1.2 Smiths’ Vital Care Segment 200
6.27.1.3 Smiths’ Safety Segment 200
6.27.2 Syringes from Smiths 201
6.27.2.1 Hypodermic Needle-Pro Fixed Needle TB Syringe 201
6.27.2.2 Hypodermic Needle-Pro Device 201
6.27.2.3 Hypodermic Needle-Pro Device andamp; Syringe 203
6.27.2.4 Hypodermic Needle-Pro Device for Insulin Injections 204
6.27.2.5 Hypodermic Needle-Pro Fixed Needle Insulin Syringe 204
6.28 Star Syringe Ltd. 205
6.28.1 Star Syringe’s Alliances 205
6.28.2 Star Syringe Products 207
6.28.2.1 K Safety Technology: K1 Auto-disable Syringe Mechanism 207
6.28.2.2 K3 Safety Cap 207
6.28.2.3 K5 Aspiration 207
6.29 Terumo Medical Corporation 207
6.29.1 Terumo’s Syringe Products 208
6.29.1.1 SurGuard2 Syringes with Safety Needle 208
6.29.1.2 SurGuard2 Safety Needles 209
6.29.1.3 Terumo Hypodermic Needles 210
6.29.1.4 Terumo Hypodermic Syringes without Needle 211
6.29.1.5 Terumo Tuberculin Syringes 212
6.29.1.6 Terumo Hypodermic Syringes with Needle 213
6.29.1.7 SurSaver 1CC syringes with Low Dead Space 214
6.29.1.8 Terumo Dental Needles 214
6.29.1.9 Terumo Spinal Needles 215
6.29.1.10 SurGuard Safety Insulin Syringes 215
6.29.1.11 Terumo Insulin Syringes 216
6.29.1.12 Thinpro Insulin Syringes for Retail Customers 216
6.30 UltiMed, Inc. 217
6.30.1 UltiCare Insulin Syringes 217
6.30.2 UltiCare Pen Needles 218
6.31 Unilife Medical Solutions, Ltd. 219
6.31.1 Unilife’s Solutions 219
6.31.2 Prefilled Syringes from Unilife 219
6.31.3 Clinical (Hypodermic) Syringes from Unilife 219
6.31.4 Unilife’s Self Injection Systems 220
6.31.4.1 Auto-Injectors 220
6.31.4.2 Unilife’s Auto-Infusers 220
6.31.5 Unilife’s Syringe Products 221
6.31.5.1 Unifill Syringe 221
6.31.5.2 Unitract 1 ml Syringes 221
6.31.5.3 Unifill Select 222
6.31.5.4 Unifill Rita 222
6.31.5.5 Unifill EZMix syringes 222
6.31.5.6 Unilife Autoinfuser 222
6.32 Vetter Pharma-Fertigung GmbH andamp; Co. 223
6.32.1 Vetter Services and Solutions 223
6.32.2 Vetter’s Dual-Chamber Technology 223
6.33 Vita Needle Company, Inc. 224
6.33.1 Disposable Stainless Steel Needle Blunts from Vita Needle 224
6.33.2 Teflon Dispensing Needles 224
6.33.3 Vita Needle’s Polypropylene Needles 225
6.33.4 Vita Needle’s Taper Tip Needles 225
6.34 West Pharmaceutical Services, Inc. 226
6.34.1 West’s Business Segments 226
6.34.1.1 Packaging Systems Segment 226
6.34.1.2 Delivery Systems Segment 226
6.34.2 West’s Syringe Products 227
6.34.2.1 The West ConfiDose Autoinjector System 227
6.34.2.2 West’s Prefillable Syringes 228
6.34.2.3 Plungers 229
6.34.2.4 Needle Shields 230
6.34.2.5 Tip Caps 230
6.35 Wuxi Yushou Medical Appliances Co., Ltd. 230
6.36 Ypsomed Holding AG 230
6.36.1 Future Trends in Self Medication: Ypsomed Holding’s Perceptions 231
6.36.2 ServoPen 233
6.36.3 YpsoPen Twist 234
6.36.4 UnoPen 234
6.36.5 LyoTwist 235
6.36.6 YpsoMate 235
6.36.7 Mylife OmniPod insulin patch pump 235


APPENDIX

Appendix 1: Global Market for Conventional Injectables 236
Appendix 1.1: Global Market for Drug Delivery Devices 237
Appendix 1.2: Evolving Trends in Insulin Delivery 238
Appendix 1.2.1: Alternative Modes of Insulin Delivery 238
Appendix 1.2.2: Insulin Injection Ports 239
Appendix 1.2.3: Continuous Subcutaneous Insulin Infusion Pumps 239
Appendix 1.2.4: Transdermal Patches 240
Appendix 1.2.5: Inhalable Insulin Devices 241
Appendix 1.3: Global Burden of Diabetes 241
Appendix 1.3.1: Market for Insulin Delivery Devices 242
Appendix 1.3.2: Leaders in Insulin Delivery Devices 242
Appendix 1.3.3: Global Insulin Consumption 243
Appendix 1.3.4: Global Market for Insulin 244
Appendix 1.4: Global Diabetes Care Market Share by Company 245
Appendix 1.4.1: Global Insulin Market by Molecule Type 245
Appendix 1.4.2: Global Insulin Market by Geography 246
Appendix 1.4.3: Global Diabetes Care Market by Treatment Class 246
Appendix 1.5: Growth of Modern Insulin 247
Appendix 1.5.1: Global Modern Insulin Market Shares 248
Appendix 1.6: U.S. Insulin Market by Segment 249
Appendix 1.6.1: U.S. Modern Insulin Volume Market Shares 250
Appendix 1.7: E.U. Insulin Market by Segment 251
Appendix 1.7.1: E.U. Modern Insulin Volume Market Share by Company 252
Appendix 1.8: Chinese Insulin Market by Segment 253
Appendix 1.8.1: China Insulin Volume Market Shares 254
Appendix 1.9: Japan Insulin Market by Segment 255
Appendix 1.9.1: Japan Modern Insulin Market Share by Company 256
Appendix 2: Sharps Safety Products 257
Appendix 3: Syringe Needle Terminology 290
Appendix 4: Medication Errors and Syringe Safety 292
Appendix 4.1: Injectable Medication Errors 292
Appendix 4.2: Frequency of Syringe Usage 292
Appendix 4.3: Labeling Injectable Medications 292
Appendix 4.4: Challenges of Labeling 292
Appendix 4.5: Benefits of a Write-On Stripe 292
Appendix 4.6: Nurses Influence on Selection of Sharp Devices 293
Appendix 4.7: Needlestick Injuries 293
Appendix 4.8: Prevention of Needlestick Injuries 293
Appendix 4.9: Protection from Needlestick Injuries 294


INDEX OF FIGURES

Figure 2.1: Filling and Packaging of Prefilled Syringes 26
Figure 4.1: Most Common Instances When Needlesticks Occur 48
Figure 4.2: Needlestick Injuries in Massachusetts at Healthcare Facilities with
Safety vs. Standard Syringes 51
Figure 4.3: Indicative Pricing Chart for Safety Features 52
Figure 5.1: Syringe Sizes Required for Injectable Drugs 59
Figure 5.2: Global Market for Disposable Syringes, 2012-2019 60
Figure 5.3: Global Market for Disposable Syringes by Segmentation, 2012 61
Figure 5.4: Global Market for Safety Syringes by Segmentation (Total $1.96
Billion), 2011 62
Figure 5.5: Combined Market for Drug Delivery Syringe Devices, 2010-2015 63
Figure 5.6: Breakdown of U.S. Syringe Market 64
Figure 5.7: Types of Safety Syringes used in the U.S. Healthcare Facilities 65
Figure 5.8: Percentage of U.S. Adoption of Safety Syringes, 2012-2019 66
Figure 5.9: The Total Disposable Syringe Market in the U.S., 2012-2019 67
Figure 5.10: The U.S. Market for Hypodermic Safety Syringes, 2012-2019 68
Figure 5.11: European Overall Market for Disposable Syringes, 2011-2019 68
Figure 5.12: European Adoption of Safety Syringes, 2012-2019 69
Figure 5.13: Market Share of Prefilled Syringes by Geography 72
Figure 5.14: Number of Drugs in the Core Therapeutic Areas for Prefilled
Syringes 75
Figure 5.15: Global Market for Prefilled Syringes, 2012-2019 93
Figure 5.16: Steady Growth of Global Prefilled Syringe Unit Consumption,
2012-2019 93
Figure 5.17: World vs. U.S. Market for Prefilled Syringes, 2012-2019 94
Figure 5.18: Consumption of Prefilled Syringes by Pharmaceutical Company 95
Figure 5.19: Pharmaceutical Consumption of Prefilled Syringes by Therapeutic
Drug Class 95
Figure 5.20: Global Market for Prefilled Pain Management Drugs, 2012-2019 97
Figure 5.21: Global Sales of Enbrel in Prefilled Syringes 97
Figure 5.22: Global Market for Prefilled Psoriasis Drugs, 2012-2019 98
Figure 5.23: Global Market for Prefilled Anemia Drugs, 2012-2019 99
Figure 5.24: Global Market for Prefilled Insulin, 2012-2019 100
Figure 5.25: Growth of Prefilled Insulin Devices and Decline of Vials and
Syringes 101
Figure 5.26: Global Market for Oncology Drugs in Prefilled Syringes, 2012-2019
102
Figure 5.27: Global Market for Multiple Sclerosis Drugs in Prefilled Syringes,
2012-2019 102
Figure 5.28: Market Share for Multiple Sclerosis Drugs in Prefilled Syringes by
Company 103
Figure 5.29: Global Market for Arthritis Drugs in Prefilled Syringes, 2012-2019
104
Figure 5.30: Percent Growth of Vaccines in Prefilled Syringes, 2012-2019 105
Figure 5.31: Market Share for Vaccines in Prefilled Syringes by Company 106
Figure 5.32: Market Share for Anti-Coagulants in Prefilled Syringes by Company
106
Figure 5.33: Market Share for Anti-Inflammatory Drugs in Prefilled Syringes 107
Figure 5.34: Market Share for Hematology Drugs in Prefilled Syringes by Company
108
Figure 5.35: Market Share for Obstetrics Drugs in Prefilled Syringes by Company
108
Figure 5.36: Global Market for Insulin Pen, 2012-2019 112
Figure 5.37: Global Market for Auto-Injectors/Auto-Infusers, 2012-2019 113
Figure 5.38: U.S. Leaders in Insulin Pumps 113
Figure 5.39: Market for Self-Injection Syringes, 2012-2019 114
Figure 6.1: BD Business Performance by Segment, 2012 122
Figure 6.2: Performance of BD Medical Segment, 2012 122
Figure 6.3: Performance of BD Diagnostics Segment, 2012 123
Figure 6.4: BD’s Geographic Performance, 2012 124
Figure 6.5: Share of Bioject’s Business by Customer 147
Figure 6.6: Bioject’s Business by Product Line 148
Figure 6.7: Bioject’s Business by Geography 149
Figure 6.8: Catalent’s Revenue by Segment 152
Figure 6.9: Retractable Technologies’ Business by Geography 194
Figure 6.10: Smiths’ Market by Segment 199
Figure 6.11: Insulin Market by Geography, 2009-2015 231
Figure 6.12: Global Insulin Market by Manufacturers, 2009-2015 232
Figure A.1.1: Global Market for Conventional Injectables, 2012-2019 237
Figure A.1.2: Global Market for Injection, Infusion and Vascular Access Devices,
2012-2019 237
Figure A.1.3: Global Burden of Diabetes, 2010-2030 241
Figure A.1.4: Global Market for Insulin Delivery Devices, 2009-2016 242
Figure A.1.5: Insulin Delivery Devices Worldwide Market Shares by Company 243
Figure A.1.6: Insulin Consumption in Selected Countries 244
Figure A.1.7: Global Market for Insulin, 2012-2019 244
Figure A.1.8: Global Diabetes Care Market Share by Company, 2012 245
Figure A.1.9: Global Insulin Market Breakup by Molecule (~ $19 Billion), 2012
246
Figure A.1.10: Global Insulin Market by Geography, 2012 246
Figure A.1.11: Global Diabetes Care Market by Treatment Class, 2002-2012 247
Figure A.1.12: Shares of Human Insulin and Modern Insulin in Global Insulin
Market, 2007-2012 248
Figure A.1.13: Global Insulin Volume Market Shares by Company, 2007-2012 249
Figure A.1.14: U.S. Insulin Market by Segment, 2007-2012 250
Figure A.1.15: U.S. Modern Insulin Volume Market Share by Company, 2007-2012 251
Figure A.1.16: E.U. Insulin Market by Segment, 2007-2012 252
Figure A.1.17: E.U. Modern Insulin Volume Market Share by Company, 2007-2012 253
Figure A.1.18: Chinese Insulin Market by Segment, 2007-2012 254
Figure A.1.19: China Insulin Volume Market Share by Company, 2012 255
Figure A.1.20: Japan Insulin Market by Segment, 2007-2012 255
Figure A.1.21: Japan Modern Insulin Market Share by Company, 2007-2012 256
Figure A.4.1: Timing of Needlestick Injuries 293


INDEX OF TABLES

Table 2.1: Components of a Prefilled Syringe 23
Table 2.2: Key Advantages of Prefilled Syringes 26
Table 2.3: Insulin Pens Available in the U.S. 33
Table 2.4: Types of Insulins Used in Cartridges 34
Table 2.5: Aspects of Insulin Pens to be considered 35
Table 2.6: User Characteristics of Insulin Pens 36
Table 5.1: Selected Injectable Therapeutics and Vaccines Available in the U.S.
Market 70
Table 5.2: Key Advantages of Prefilled Syringes 73
Table 5.3: Pharmaceutical Share of Key Prefilled Therapeutic Market 73
Table 5.4: Key Prefilled Products 74
Table 5.5: Biotech Blockbusters Available in Vials and Prefilled Syringes 78
Table 6.1: Albert David’s Syringes with Needles 117
Table 6.2: Albert David’s Needles 117
Table 6.3: Syringes from Alshifa 118
Table 6.4: BD’s Auto-Disable Syringes 129
Table 6.5: Insulin Syringes from BD 130
Table 6.6: BD’s Allergy Syringes 131
Table 6.7: BD’s Tuberculin Syringes 131
Table 6.8: BD’s Sterile, Single-Use Syringes and Needles 132
Table 6.9: BD’s Safety-Lok Safety Syringes 134
Table 6.10: BD’s Safety Glide Syringes 135
Table 6.11: BD’s Eclipse Syringes 135
Table 6.12: BD’s Integra Syringe 136
Table 6.13: BD’s PosiFlush Prefilled Syringes 137
Table 6.14: Bard’s Piston Syringes 155
Table 6.15: Bard’s Bulb Syringes and Trays, 2009 155
Table 6.16: Angiographic Syringes from Coeur 156
Table 6.17: CT Syringes from Coeur 157
Table 6.18: HMD’s Dispovan Insulin Syringes 167
Table 6.19: HMD’s Single-Use Needles 167
Table 6.20: HMD’s Single Use Syringes 168
Table 6.21: Hi-Tech Single-Use Syringes 168
Table 6.22: Hi-Tech’s Single-Use Insulin Syringes 169
Table 6.23: HCM’s Contract Manufacturing Categories 170
Table 6.24: Syringes from IMS 171
Table 6.25: PCA Syringes from IMS 172
Table 6.26: Phytonadione Injection USP from IMS 172
Table 6.27: Lidocaine Prefilled Syringes from IMS 173
Table 6.28: Life-Shield’s Syringe Products 174
Table 6.29: Estimated Market for MedPro’s Targeted Product Sectors 175
Table 6.30: Autopen Products from Owen Mumford 188
Table 6.31: Autoject Products from Owen Mumford 188
Table 6.32: Unifine Products from Owen Mumford 189
Table 6.33: Retractable Technologies’ VanishPoint Syringes 193
Table 6.34: Smiths’ Pro Fixed Needle TB Syringes 200
Table 6.35: Smiths’ Needle-Pro with Needle Protection Devices 201
Table 6.36: Smiths’ Needle-Pro Syringe and Needle with Needle Protection Device
202
Table 6.37: Smiths’ Needle-Pro Needle Protection Device for Insulin Injections
203
Table 6.38: Smiths’ Needle-Pro Fixed Needle Insulin Syringe 204
Table 6.39: SurGard2 Syringes with Safety Needle 208
Table 6.40: Terumo’s SurGard2 Safety Needles 209
Table 6.41: Terumo’s Hypodermic Needles 210
Table 6.42: Terumo’s Hypodermic Syringes without Needle 211
Table 6.43: Terumo’s Tuberculin Syringes 211
Table 6.44: Terumo’s Hypodermic Syringes with Needle 212
Table 6.45 Terumo’s SurSaver 1 cc Syringes with Low Dead Space 213
Table 6.46: Terumo’s Dental Needles 213
Table 6.47: Terumo’s Spinal Needles 214
Table 6.48: Terumo’s SurGard Safety Insulin Syringes 215
Table 6.49: Terumo’s Insulin Syringes 215
Table 6.50: Thinpro Insulin Syringes 216
Table 6.51: UltiMed’s UltiCare Insulin Syringes 217
Table 6.52: UltiCare Pen Needles 217
Table 6.53: Vita Needle’s Stainless Steel Needle Blunts 223
Table 6.54: Vita Needle’s Teflon Dispensing Needles 224
Table 6.55: Vita Needles Polypropylene Needles 224
Table 6.56

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Global Wound Care Market Outlook

Global Wound Care Market Outlook

  • $ 8 000
  • Industry report
  • October 2014
  • by Frost & Sullivan

Analysis of Wound Care Technologies The global wound care market is at a growth stage. It is driven by the increasingly aging population as well as rising rates of diabetes and obesity. These chronic health ...

World Medical Disposables Market

World Medical Disposables Market

  • $ 6 400
  • Industry report
  • September 2014
  • by Freedonia

World medical disposables demand to increase 6.6% annually through 2018 The Freedonia Group projects that world demand for disposable medical supplies will increase 6.6 percent yearly to nearly $245 billion ...

Disposable Medical Supplies Markets

Disposable Medical Supplies Markets

  • $ 3 400
  • Industry report
  • July 2014
  • by TriMark Publications

The purpose of this TriMark Publications report is to give an insight into the specific market segment called disposable medical supplies. Disposable medical supplies represent the largest segment within ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.